宫内hCG和子宫内膜受体性之间的分子交叉:试管婴儿中的信号通路,免疫调节和转化前景
Charalampos Voros1, Fotios Chatzinikolaou2, Georgios Papadimas3
11st Department of Obstetrics and Gynecology, 'Alexandra' General Hospital, National and Kapodistrian University of Athens, 80 Vasilissis Sofias Avenue, 11528 Athens, Greece.
International journal of molecular sciences
|January 10, 2026
概括
人体胆管性腺激素 (hCG) 通过调节多个细胞过程来增强子宫内膜受体. 这篇评论详细介绍了hCG的细节.
科学领域:
- 生殖生物学 生殖生物学
- 分子内分泌学分子内分泌学
- 免疫学 免疫学 免疫学
背景情况:
- 子宫内膜受容性是胚胎植入的关键窗口,受复杂的分子相互作用的影响.
- 对于体外受精 (IVF) 中子宫内人类胆管性淋巴激素 (hCG) 用于子宫内膜原料的临床结果是可变的.
- 了解hCG的分子机制是优化其在辅助生殖中的使用的关键.
研究的目的:
- 审查分子数据关于人类胆性淋巴激素 (hCG) 如何影响子宫内膜受体.
- 阐明受子宫内hCG影响的细胞和分子通路.
- 为hCG在试管婴儿中的临床应用提供科学基础.
主要方法:
- 现有关于hCG在子宫内膜中的作用的分子和临床数据的叙述性综述.
- 通过hCG调节的信号通路,基因表达和细胞相互作用的分析.
- 综合证据关于hCG对上皮质,内皮质,肌层和免疫区的影响.
主要成果:
- hCG通过miR-126-3p-PIK3R2-PI3K/Akt轴增强了上皮质的粘附和增殖.
- 宫内hCG可以加强内皮结节 (VE-cadherin,CD146),但不促进血管生成.
- hCG调节体过程 (自,亡,类固醇受体) 并启动体标记物 (ACTA2,NOTCH1).
- hCG通过增强调节性T细胞和改变自然杀手细胞分布来调节免疫环境,促进耐受性和螺旋动脉重塑.
结论:
- hCG对子宫内膜产生性作用,通过协调的分子和细胞调节来增强受体.
- 这些分子作用为对子宫内hCG的情境依赖性临床反应提供了科学理由.
- 在试管婴儿中,针对子宫内hCG的优化,患者指导的分娩方法可能会改善结果.
关键词:
在 PI3K/Akt/eNOS 发送信号时.胚胎植入 胚胎植入宫内膜的受体性 宫内膜的受体性人类胆管性淋巴激素人类胆管性淋巴激素.在体外受精 in vitro受精黄素激素 / 胆激素受体受体树叶的脱落是因为树叶的脱落.更多相关视频
05:13Author Spotlight: Advancing Therapeutic Strategies for Improving Pregnancy Rates by Analyzing Embryo-Endometrium Interactions
Published on: June 21, 2024
1.6K
05:16Multiplexed Fluorescent Immunohistochemical Staining of Four Endometrial Immune Cell Types in Recurrent Miscarriage
Published on: August 4, 2021
3.7K
相关概念视频
01:15Transcytosis of IgG
4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K
01:27Ovarian Cycle
3.4K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
3.4K
01:24In Vitro Fertilization
874
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
874
02:07Oogenesis
69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K